9.ALPHA.-FLUORO-11.BETA.,17.BETA.-DIHYDROXY-2.ALPHA.,17-DIMETHYL-4-ANDROSTEN-3-ONE
UNII H2DZZ8T69A
Substance Identification & Data
This profile provides standardized clinical and technical data for 9.alpha.-fluoro-11.beta.,17.beta.-dihydroxy-2.alpha.,17-dimethyl-4-androsten-3-one, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H2DZZ8T69A.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1827-65-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H31FO3 ZVKKSLFHXTYQQE-NIMMKTQNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9.alpha.-fluoro-11.beta.,17.beta.-dihydroxy-2.alpha.,17-dimethyl-4-androsten-3-one. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.